Home > Signaling Pathways>Epigenetics>Epigenetic Reader Domain>CPI-203 (RO-6870810, TEN-010, JQ2, and RG-6146)
CPI-203 (RO-6870810, TEN-010, JQ2, and RG-6146)

This product is for research use only, not for human use. We do not sell to patients.

CPI-203 (RO-6870810, TEN-010, JQ2, and RG-6146)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
250mg$1250Check With Us
500mg$1950Check With Us
1g$2925Check With Us

Cat #: V0424 CAS #: 1446144-04-2 Purity ≥ 98%

Description: CPI-203 (RO6870810, JQ-2, TEN010, RG6146) is a novel, selective, cell permeable and orally bioavailable BET bromodomain inhibitor with anticancer activity.

References: Devaiah BN, et al. BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain. Proc Natl Acad Sci U S A. 2012 May 1;109(18):6927-32.  

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)399.90
Molecular FormulaC19H18ClN5OS
CAS No.1446144-04-2
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: 79 mg/mL (197.54mM)r
Water: <1 mg/mLr
Ethanol: 5 mg/mL (12.5 mM)
SMILES CodeO=C(N)C[C@H]1C2=NN=C(C)N2C3=C(C(C)=C(C)S3)C(C4=CC=C(Cl)C=C4)=N1
SynonymsRO-6870810; CPI203; CPI-203; CPI 203;RO 6870810; TEN010; RG 6146; RG-6146; TEN 010; TEN010; JQ-2; JQ 2; JQ2; RG-6146; RO6870810;
ProtocolIn VitroCPI-203 inhibits BRD4 in vitro and in cells, but does not affect BRD4 kinase activity in vitro.
In VivoCPI-203 (2.5 mg/kg, i.p.) combined with lenalidomide, enhances the antitumoral properties of each single agent via the abrogation of MYC and IRF4 expression and the induction of apoptosis in n REC-1 tumor-bearing mice.
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM2.5006 mL12.5031 mL25.0063 mL50.0125 mL
5mM0.5001 mL2.5006 mL5.0013 mL10.0025 mL
10mM0.2501 mL1.2503 mL2.5006 mL5.0013 mL
20mM0.1250 mL0.6252 mL1.2503 mL2.5006 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.